Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Beyond their established role in T2D, GLP-1RAs are under investigation for potential therapeutic applications in additional clinical domains: non-alcoholic fatty liver disease (NAFLD) [22], neurodegenerative conditions [23], and addiction reduction(including smoking, alcohol use disorder, and cocaine use disorder, putatively via mechanisms analogous to those underlying appetite suppression) [23]
& Christensen, M
That statement has drawn a lot of criticism because, as other researchers rightly point out, we lack the human safety data and "to date, no published in vivo data demonstrate that BPC 157 inhibits tumor progression, reduces tumor volume, or suppresses metastasis" [16]
Because these compounds mimic or change normal signalling, they usually function with your biology instead of against it
